CD5 antibody (CD5 Molecule) (PE)

Details for Product anti-CD5 Antibody No. ABIN356205, Supplier: Log in to see
Antigen
  • CD5
  • Ly-1
  • Ly-12
  • Ly-A
  • Lyt-1
  • LEU1
  • T1
  • CD5 molecule
  • CD5 antigen
  • CD5 antigen-like
  • Cd5 molecule
  • CD5
  • Cd5
  • LOC100054450
Reactivity
Mouse (Murine)
819
263
146
75
53
39
35
35
34
29
28
27
25
21
17
5
2
2
1
Host
Rat
953
207
137
1
Clonality (Clone)
Monoclonal ()
Conjugate
This CD5 antibody is conjugated to PE
146
133
104
51
32
30
27
25
22
22
19
19
19
19
19
19
15
15
9
8
8
7
6
5
5
5
4
2
2
2
2
2
2
1
1
1
1
1
1
1
Application
Functional Studies (Func), Flow Cytometry (FACS), Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunoprecipitation (IP), Western Blotting (WB)
1026
403
313
288
248
190
178
161
136
17
15
14
13
11
10
8
6
6
4
3
3
2
2
1
1
1
1
1
1
1
1
Options
Supplier
Log in to see
Supplier Product No.
Log in to see
Request

Get this product for free

It's quick and easy to submit your validation proposal. I want to validate this product

Learn more

Available images

Clone 4H8E6
Isotype IgG2a
Specificity This antibody is specific to CD5/Lyt-1 (Mr. 67 kDa)
Characteristics Synonyms: Lymphocyte antigen T1/Leu-1, LEU1, T-cell surface glycoprotein CD5
Alternative Name CD5 (CD5 Antibody Abstract)
Background CD5/Lyt-1 antigen is a monomeric type I transmembrane glycoprotein expressed on thymocytes, T lymphocytes, and a subset of B lymphocytes, but not on natural killer (NK) cells. (Ref.1-3) It has been identified as the major ligand of the B-cell antigen CD72. (Ref.4,5) The frequency of CD5+ B cells exhibits strain-dependent variation, and the phenotypic, anatomical, functional, developmental, and pathological characteristics of the CD5+ B cells suggest that they may represent a distinct lineage, known as B-1 cells (reviewed in Ref.6). Binding of CD5 on the T cell surface can augment alloantigen- or mitogen-induced lymphocyte proliferation and induces increased cytosolic free calcium, IL-2 secretion, and IL-2R expression. (Ref.7-12) It has been proposed that CD5 negatively regulates signal transduction mediated by the T-cell and B-cell receptors. (Ref.13,14)Synonyms: CD5, LEU1, Lymphocyte antigen T1/Leu-1, T-cell surface glycoprotein CD5
Gene ID 12507
UniProt P13379
Research Area Stem Cells, Hematopoietic Progenitors, Adaptive Immunity, CD Antigens, Surface Receptors of Immune Cells
Application Notes Flow Cytometry: Identification and enumeration of CD5+ cells (< / = 0.2 μg/10^6 cells). (Ref.15)Immunoprecipitation. (Ref.15)Immunohistochemistry on Frozen Sections. (Ref.15)T Cell Activation. (Ref.15)Western blotting. (Ref.15)
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user.
Restrictions For Research Use only
Concentration 0.1 mg/mL
Buffer PBS containing 0.09 % Sodium Azide as preservative and a stabilizing agent.
Preservative Sodium azide
Precaution of Use This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage 4 °C
Storage Comment Store the antibody undiluted at 2-8 °C. DO NOT FREEZE! This product is photosensitive and should be protected from light. Avoid repeated freezing and thawing.
Shelf life: one year from despatch.
Expiry Date 12 months
Supplier Images
Flow Cytometry (FACS) image for anti-CD5 antibody (CD5 Molecule)  (PE) (ABIN356205) anti-CD5 Molecule (CD5) antibody (PE)
Background publications Bikah, Carey, Ciallella, Tarakhovsky, Bondada: "CD5-mediated negative regulation of antigen receptor-induced growth signals in B-1 B cells." in: Science (New York, N.Y.), Vol. 274, Issue 5294, pp. 1906-9, 1997 (PubMed).

Tarakhovsky, Kanner, Hombach, Ledbetter, Müller, Killeen, Rajewsky: "A role for CD5 in TCR-mediated signal transduction and thymocyte selection." in: Science (New York, N.Y.), Vol. 269, Issue 5223, pp. 535-7, 1995 (PubMed).

Kantor, Herzenberg: "Origin of murine B cell lineages." in: Annual review of immunology, Vol. 11, pp. 501-38, 1993 (PubMed).

Luo, Van de Velde, von Hoegen, Parnes, Thielemans: "Ly-1 (CD5), a membrane glycoprotein of mouse T lymphocytes and a subset of B cells, is a natural ligand of the B cell surface protein Lyb-2 (CD72)." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 148, Issue 6, pp. 1630-4, 1992 (PubMed).

Van de Velde, von Hoegen, Luo, Parnes, Thielemans: "The B-cell surface protein CD72/Lyb-2 is the ligand for CD5." in: Nature, Vol. 351, Issue 6328, pp. 662-5, 1991 (PubMed).

Verwilghen, Vandesande, Vandenberghe, Ceuppens: "Crosslinking of the CD5 antigen on human T cells induces functional IL2 receptors." in: Cellular immunology, Vol. 131, Issue 1, pp. 109-19, 1990 (PubMed).

June, Rabinovitch, Ledbetter: "CD5 antibodies increase intracellular ionized calcium concentration in T cells." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 138, Issue 9, pp. 2782-92, 1987 (PubMed).

Stanton, Stevens, Ledbetter, Wofsy: "Anti-Ly-1 antibody induces interleukin 2 release from T cells." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 136, Issue 5, pp. 1734-7, 1986 (PubMed).

Seaman, Wofsy, Greenspan, Ledbetter: "Treatment of autoimmune MRL/Ipr mice with monoclonal antibody to Thy-1.2: a single injection has sustained effects on lymphoproliferation and renal disease." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 130, Issue 4, pp. 1713-8, 1983 (PubMed).

Hollander: "Effects of anti-Lyt antibodies on T-cell functions." in: Immunological reviews, Vol. 68, pp. 43-66, 1983 (PubMed).

Hollander, Pillemer, Weissman: "Effects of Lyt antibodies on T-cell functions: augmentation by anti-Lyt-1 as opposed to inhibition by anti-Lyt-2." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 78, Issue 2, pp. 1148-51, 1981 (PubMed).

Ledbetter, Herzenberg: "Xenogeneic monoclonal antibodies to mouse lymphoid differentiation antigens." in: Immunological reviews, Vol. 47, pp. 63-90, 1980 (PubMed).

Ledbetter, Rouse, Micklem, Herzenberg: "T cell subsets defined by expression of Lyt-1,2,3 and Thy-1 antigens. Two-parameter immunofluorescence and cytotoxicity analysis with monoclonal antibodies modifies current views." in: The Journal of experimental medicine, Vol. 152, Issue 2, pp. 280-95, 1980 (PubMed).